During the past decade, Georgia Kidney Associates, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Georgia Kidney Associates, Inc." are "Chronic Kidney Disease" (1 trials), "Chronic Renal Insufficiency" (1 trials), "Renal Failure" (1 trials) and "Secondary Hyperparathyroidism" (1 trials). Many other conditions were trialed in "Georgia Kidney Associates, Inc." in a lesser frequency.

Most popular intervention types in "Georgia Kidney Associates, Inc." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Calcium-based phosphate binder" (1 trials), "Hectorol (doxercalciferol capsules), 0.5mcg" (1 trials) and "Sevelamer hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georgia Kidney Associates, Inc." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Georgia Kidney Associates, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Georgia Kidney Associates, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Georgia Kidney Associates, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".